The contentious multigenerational and affordable housing project on 10 Still Creek Road was approved in a 4-1 vote by the ...

Outra briga que dói no coração dos fãs das séries envolve Sarah Jessica Parker e Kim Cattrall. Se em Sex and the City ambas ...

The move: Moderna stock popped, before paring losses as investors eye it as a play on the emerging hantavirus threat. Shares opened Monday's session higher, with the stock peaking around 22% from ...

Moderna Inc. said it’s researching vaccines to protect against hantaviruses, even as public health experts downplay the risk the deadly pathogen aboard a cruise ship could become a significant threat.

Veja palpites de Cruzeiro x Atlético-MG, análise detalhada e onde assistir em 02/05. Jogue com responsabilidade!

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat CAMBRIDGE, MA / ACCESS Newswire / April ...

Shares of Moderna on Wednesday surged to their highest in more than a year after the pharmaceutical company said it reached a deal to resolve a dispute related to its COVID vaccine. Moderna MRNA said ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.